- Prasco begins distribution of doxercalciferol capsules
- Perrigo recalls APAP infant suspension liquid due to the possibility of missing dose markings on the dosing syringe
- Perrigo launches generic equivalent to prescription-only Vanos Cream 0.1%
- Prasco enters distribution deal with Shire for kidney disease drug
- Perrigo approved for generic Prandin
ALLEGAN, Mich. — The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.
Perrigo announced the approval of calcium acetate capsules, a generic version of Nabi Biopharmaceuticals' Phoslo Gelcaps. The drug is used to treat end-stage renal failure.
Perrigo settled a patent infringement lawsuit concerning the drug last year, though terms of the settlement were not disclosed. Annual sales of the branded version of the drug and generic versions were $95 million, according to Wolters Kluwer Health.